P
Paul Garner
Researcher at Liverpool School of Tropical Medicine
Publications - 409
Citations - 20214
Paul Garner is an academic researcher from Liverpool School of Tropical Medicine. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 68, co-authored 327 publications receiving 16164 citations. Previous affiliations of Paul Garner include University of Paris & Cochrane Collaboration.
Papers
More filters
Journal ArticleDOI
Directly observed treatment for tuberculosis.
Paul Garner,Jimmy Volmink +1 more
TL;DR: By using a six month course of drugs, including rifampicin, the World Health Organization has mobilised money, people, and systems in countries to tackle the global problem of inadequate tuberculosis control with good progress.
Journal ArticleDOI
GRADE Guidance 24. Optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines.
Carlos A. Cuello-Garcia,Carlos A. Cuello-Garcia,Pankaj C. Patel,Nancy Santesso,Rebecca L. Morgan,Jos Verbeek,Kris Thayer,Mohammed T. Ansari,Joerg J Meerpohl,Joerg J Meerpohl,Lukas Schwingshackl,Srinivasa Vittal Katikireddi,Jan Brozek,Barnaby C Reeves,Mohammad Hassan Murad,Maicon Falavigna,Reem A. Mustafa,Reem A. Mustafa,Deborah L. Regidor,Paul E. Alexander,Paul Garner,Elie A. Akl,Gordon H. Guyatt,Holger J. Schünemann +23 more
TL;DR: In this paper, the authors describe the GRADE approach for assessing the certainty of a body of evidence in systematic reviews and health technology assessments and how to move from evidence to recommendations in guidelines.
Journal ArticleDOI
Human host selection by anophelines: no evidence for preferential selection of malaria or microfilariae-infected individuals in a hyperendemic area.
TL;DR: Host selection among humans by Anopheles punctulatus was studied in an area of Papua New Guinea endemic for malaria and filariasis, with no significant differences in axillary temperatures between malaria or microfilariae positive or negative individuals.
Reference EntryDOI
Mefloquine for preventing malaria in non‐immune adult travellers
Ashley M Croft,Paul Garner +1 more
TL;DR: There is evidence from non-randomised studies that mefloquine is a potentially harmful drug for tourists and business travellers, needing more careful evaluation, and a randomised tolerability study is urgently needed in these groups.
Journal ArticleDOI
Trichomoniasis treatment in women : a systematic review
A M Gülmezoglu,Paul Garner +1 more
TL;DR: To compare the effectiveness of various treatment strategies for trichomoniasis in women, a large number of patients with known or suspected cases of the disease are referred to a single treatment programme.